These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2828404

  • 21. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
    Livesey JH, Donald RA, Irvine CH, Redekopp C, Alexander SL.
    Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
    [Abstract] [Full Text] [Related]

  • 22. A short negative feedback mechanism regulating corticotropin-releasing hormone release.
    Suda T, Tomori N, Yajima F, Ushiyama T, Sumitomo T, Nakagami Y, Demura H, Shizume K.
    J Clin Endocrinol Metab; 1987 May; 64(5):909-13. PubMed ID: 3031120
    [Abstract] [Full Text] [Related]

  • 23. Beta-endorphin attenuates the serum cortisol response to exogenous adrenocorticotropin.
    Beyer HS, Parker L, Li CH, Stuart D, Sharp BM.
    J Clin Endocrinol Metab; 1986 May; 62(5):808-11. PubMed ID: 3007553
    [Abstract] [Full Text] [Related]

  • 24. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 25. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J, Balm PH, Ruane NM, Pérez-Sánchez J, Wendelaar-Bonga SE, Tort L.
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [Abstract] [Full Text] [Related]

  • 26. Response to corticotropin-releasing hormone during pregnancy in the baboon.
    Goland RS, Stark RI, Wardlaw SL.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):925-9. PubMed ID: 2156891
    [Abstract] [Full Text] [Related]

  • 27. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 28. Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men.
    Pavlov EP, Harman SM, Chrousos GP, Loriaux DL, Blackman MR.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):767-72. PubMed ID: 3005357
    [Abstract] [Full Text] [Related]

  • 29. Infusion of beta-endorphin has no suppressive effect on the releasing hormone-stimulated pituitary-adrenal-axis of normal human subjects.
    Schulte HM, Allolio B.
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):526-30. PubMed ID: 2175140
    [Abstract] [Full Text] [Related]

  • 30. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man.
    Oelkers W, Boelke T, Bähr V.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):181-6. PubMed ID: 2826525
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M, Shibasaki T, Shizume K, Kiyosawa Y, Odagiri E, Suda T, Yamaguchi H, Tsushima T, Demura H, Maeda T.
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [Abstract] [Full Text] [Related]

  • 34. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH, Schulte HM, Chrousos GP, Gold PW, Benker G, Peterson RE, Cutler GB, Loriaux DL.
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [Abstract] [Full Text] [Related]

  • 35. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA, Rebar RW, LaBarbera AR, Pennington EJ, Liu JH.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [Abstract] [Full Text] [Related]

  • 36. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man.
    Watabe T, Tanaka K, Kumagae M, Itoh S, Kogure M, Hasegawa M, Horiuchi T, Morio K, Takeda F, Ubukata E.
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1132-7. PubMed ID: 2836468
    [Abstract] [Full Text] [Related]

  • 37. Comparison of intravenous versus intramuscular administration of corticotropin-releasing hormone in healthy cats.
    Eiler KC, Bruyette DS, Behrend EN, Kemppainen RJ, Kass PH.
    J Vet Intern Med; 2013 Jun; 27(3):516-21. PubMed ID: 23480784
    [Abstract] [Full Text] [Related]

  • 38. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H, Tamura T.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.